Barrigel - Radiotherapy protection spacer

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Tilgængelig fra:

Palette Life Sciences Australia Pty Ltd

Klasse:

Class III

Fremstillet af:

Palette Life Sciences 27 E Cota Street Suite 402, Santa Barbara, CA, 93101 United States Of America

Terapeutisk område:

60424 - Radiotherapy protection spacer

Terapeutiske indikationer:

Barrigel is a sterile, transparent, biodegradable gel of stabilized hyaluronic acid of non-animal origin, supplied in a glass syringe. Barrigel acts by adding volume to the tissue, thereby mechanically creating an increased distance between the prostate and the anterior rectal wall. The product degrades over time. Barrigel is used to increase the distance between the prostate and the anterior rectal wall, with the intent to decrease radiation dose delivered to the rectum when treating prostate cancer with radiation.

Autorisation status:

A

Autorisation dato:

2020-07-21